Displaying items 13-24 of 108
» View wsbt.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
•
Next >
-
Novartis, BT push European shares to fresh 5-yr peak
ReutersLONDON, May 10 (Reuters) - European shares scaled fresh five-year highs on Friday, led by healthcare group Novartis and telecoms firm BT on positive corporate news, and traders said key indexes had scope for more gains. The pan-European FTSEurofirst...Tags: Earnings Forecasts, Germany
-
Novartis y BT empujan acciones europeas a máximos de 5 años
ReutersLONDRES, 10 mayo (Reuters) - Las acciones treparon el viernes a nuevos máximos de cinco años en los mercados europeos, lideradas por la farmacéutica Novartis y la firma de telecomunicaciones BT, y los operadores dijeron que los índices claves todavía... -
REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...Tags: Ernst & Young, Health Insurance Cost, Prescription Drugs, Chemical Industry, Politics
-
Telecoms stocks lift Europe equities to new peaks
Reuters* FTSEurofirst 300 ends up 0.4 pct at 1,233.49 points * Euro STOXX 50 up 0.4 pct at 2,785.24 points * DAX sets new record high * BT and Novartis boost telecom and health stocks By Sudip Kar-Gupta LONDON, May 10 (Reuters) - European shares scaled...Tags: Auto Trends, Economy, Business and Finance, Foreign Exchange Market, Healthcare Contract Issues, Market and Exchange
-
Acciones europeas cierran en nuevos máximos de 5 años
ReutersPor Sudip Kar-Gupta LONDRES, 10 mayo (Reuters) - Las acciones treparon el viernes a nuevos máximos de cinco años en los mercados europeos, lideradas por papeles farmacéuticos y de telecomunicaciones, y los operadores dijeron que los índices... -
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Food and Drug Administration, Johnson & Johnson Inc., Pfizer Inc., Rheumatoid Arthritis, Schering Plough Corporation
-
Veeva Systems planning initial public offering - sources
ReutersBy Olivia Oran April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according to two people familiar with the...Tags: Financing and Stock Offerings, AstraZeneca Plc, Morgan Stanley Dean Witter & Company, Chemical Industry, Lilly Eli & Co
-
FACTBOX-Vaccine, drugs to fight new bird flu
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) May 6 (Reuters) - The U.N. World Health Organization and the U.S. Centers for Disease Control and Prevention are already working with samples of the new H7N9...Tags: Flu, Chemical Industry, Viral Diseases and Infections, Diseases and Illnesses, Vaccines
-
REUTERS SUMMIT-Teva better suited than most for China market -CEO
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...Tags: China, Economy, Business and Finance, Israel, Corporate Officers, Environmental Illness
-
Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...Tags: Kareem Abdul-Jabbar, National Basketball Association, Leukemia, Los Angeles Lakers, Jimmy Kimmel
-
Chicago joins kickback suit against Novartis
ReutersTwenty-seven U.S. states, the District of Columbia and the cities of New York and Chicago are plaintiffs in the latest lawsuit against Novartis AG. The suit, filed Friday and the second civil fraud action against the company in four days, accuses a...Tags: Prescription Drugs, National Government, Chemical Industry, Politics, Justice System
-
U.S. files 2nd lawsuit accusing Novartis of kickbacks
ReutersApril 26 (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multi-million dollar kickbacks to doctors in exchange for prescribing its drugs....Tags: Trials, Justice System, Manhattan (New York City), Lotrel (drug), Corporate Crime
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
Apr 12, 2013
|Story| Los Angeles Times
Apr 26, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Original site for Novartis AG topic gallery.